Thomas Jefferson University

Jefferson Digital Commons
Department of Emergency Medicine Faculty
Papers

Department of Emergency Medicine

4-8-2021

The Protective Effect of Traditional Chinese Medicine on Liver
Ischemia-Reperfusion Injury.
Wen Ma
Sichuan University-The Hong Kong Polytechnic University Institute for Disaster Management and
Reconstruction, Chengdu 610207, China; Research Laboratory of Emergency Medicine, Department of
Emergency Medicine, West China Hospital, Sichuan University, Chengdu 610041, China

Songling Tang
Research Laboratory of Emergency Medicine, Department of Emergency Medicine, West China Hospital,
Sichuan University, Chengdu 610041, China

Dina Xie
Department of Emergency Medicine, Thomas Jefferson University, Philadelphia 19107, PA, USA

Guoqiang Gu
Cardiology Department, Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China
Follow this and additional works at: https://jdc.jefferson.edu/emfp

Lu Gan
Part of the Emergency Medicine Commons

Research Laboratory of Emergency Medicine, Department of Emergency Medicine, West China Hospital,
Sichuan University, Chengdu 610041, China; National Clinical Research Center for Geriatrics, West China
Hospital, Sichuan University, Chengdu 610041, China

Let us know how access to this document benefits you

Recommended Citation
Ma, Wen; Tang, Songling; Xie, Dina; Gu, Guoqiang; and Gan, Lu, "The Protective Effect of
Traditional Chinese Medicine on Liver Ischemia-Reperfusion Injury." (2021). Department of
Emergency Medicine Faculty Papers. Paper 136.
https://jdc.jefferson.edu/emfp/136
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Emergency Medicine Faculty Papers by an authorized administrator of the
Jefferson Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

Hindawi
Evidence-Based Complementary and Alternative Medicine
Volume 2021, Article ID 5564401, 5 pages
https://doi.org/10.1155/2021/5564401

Review Article
The Protective Effect of Traditional Chinese Medicine on Liver
Ischemia-Reperfusion Injury
Wen Ma ,1,2 Songling Tang ,2 Dina Xie,3 Guoqiang Gu ,4 and Lu Gan

2,5

1

Sichuan University-The Hong Kong Polytechnic University Institute for Disaster Management and Reconstruction,
Chengdu 610207, China
2
Research Laboratory of Emergency Medicine, Department of Emergency Medicine, West China Hospital, Sichuan University,
Chengdu 610041, China
3
Department of Emergency Medicine and Medicine, Thomas Jeﬀerson University, Philadelphia 19107, PA, USA
4
Cardiology Department, Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China
5
National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
Correspondence should be addressed to Guoqiang Gu; guguoqiang21@163.com and Lu Gan; wendylu1981@126.com
Received 7 February 2021; Revised 5 March 2021; Accepted 29 March 2021; Published 8 April 2021
Academic Editor: Zhiqian Zhang
Copyright © 2021 Wen Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Liver ischemia-reperfusion (I/R) injury occurs during transplantation and major hepatic surgery, which may lead to postoperative liver
dysfunction. More and more traditional Chinese medicines (TCMs) have been used to treat liver ischemia-reperfusion injury. The
purpose of this review is to evaluate the diﬀerent protective eﬀects of TCMs in the treatment of liver ischemia-reperfusion injury and to
summarize its possible mechanisms. The results indicate that TCMs attenuate liver I/R injury via multiple mechanisms, including
antioxidation stress, anti-inﬂammatory response, antiapoptosis, and inhibiting endoplasmic reticulum stress. However, the in-depth
mechanism of the protective eﬀects of these traditional Chinese medicines still remains unknown.

1. Introduction
Ischemia-reperfusion (I/R) injury is a two-stage phenomenon in which blood ﬂow into the organ is reduced,
leading to tissue hypoxia and cell damage, followed by
aggravated injury when oxygen delivery is restored [1].
Liver ischemia-reperfusion injury (I/RI) occurs during
transplantation and major hepatic surgery, which may
result in postoperative liver dysfunction [2, 3]. The cessation of blood ﬂow to an organ can lead to oxygen and
nutrient deﬁciencies which can induce inﬂammatory cell
inﬁltration, production of oxygen-derived reactive oxygen
species (ROS) and nitrogen-derived reactive nitrogen
species, and process during the reperfusion period [4].
Reperfusion injury mainly comes from toxic ROS produced
by ischemic tissue when oxygen is reintroduced. ROS can
be derived intracellularly and extracellularly, and mitochondria in liver cells are the main source of ROS [5].
Herbal medicine has drawn more and more attention in
recent years. According to the World Health Organization,

approximately 80% of the global population relies on traditional herbal medicines as part of standard health care [6].
A series of traditional Chinese medicine ingredients have
been used to treat liver ischemia-reperfusion injury and have
achieved good results (see Table 1). However, traditional
Chinese medicine is a multicomponent medicine and plays
an eﬀective role through multiple targets and pathways,
including antioxidation stress, anti-inﬂammatory response,
antiapoptosis, and inhibiting endoplasmic reticulum stress.
In this review, we summarize the eﬀects of TCMs on I/Rinduced liver injury, with focus on the possible underlying
mechanisms.

2. The Protective Effect of TCMs on Liver
Ischemia-Reperfusion Injury and
Potential Mechanisms
During I/R, some functional changes that occur at the
cellular level may cause cell damage via production of ROS,
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Table 1: The protective eﬀect of TCMs on liver ischemia-reperfusion injury and potential mechanisms.

Traditional
Chinese
medicine
Atractylodes
macrocephala
Saﬀron

Breviscapus

Salvia
miltiorrhiza

Animals

Protective eﬀects

Atractylodes macrocephala
polysaccharide (AMP)

Hepatic I/RI
model

SD rats

Antioxidation stress

Saﬀron ethanol extract
(SEE)

Hepatic I/RI
model

Wistar rats

Antioxidation stress;
inhibition of
endoplasmic reticulum
stress

—

Pan et al.
[8]

Breviscapine

Hepatic I/RI
model

SD rats

Antioxidation stress

Mfn2/RasPI3K-Akt
pathway

Lin et al.
[9]

Caﬀeic acid (CA)/3, 4dihydroxycinnamic acid

Hepatic I/RI
model

SD rats

Antioxidation stress;
Anti-inﬂammatory
response

Sirt3 signaling
pathway

Mu et al.
[10]

Caﬀeic acid (CA)/3, 4dihydroxycinnamic acid

Liver
transplantation
model

SD rats,
hepatocyte

Antioxidation stress;
anti-inﬂammatory
response

Tanshinone IIA (Tan IIA)

Gynostemma
pentaphyllum
Glycyrrhiza
uralensis
Tripterygium
wilfondii Hook F
Kudzu
Corydalis
yanhusuo
Astragalus
membranaceus

Ref.

Models

Magnesium lithospermate
B (MLB)

Huperzia serrata

Potential
mechanisms

Major active ingredients

Hepatic I/RI
model
Hepatic I/RI
model

C57BL/6 mice
C57BL/6 mice

Anti-inﬂammatory
response
Anti-inﬂammatory
response

NF-κB signaling Jin et al.
pathway
[7]

PDIA3NADPH
Mu et al.
signaling
[11]
pathway
NF-κB signaling
Song
pathway
et al. [12]
TLR4 signaling Qi et al.
pathway
[13]
Xu and
—
Wang
[14]
Zhao
—
et al. [15]
Nrf2/HO-1
Kou et al.
signaling
[16]
pathway
STAT3
Wu et al.
signaling
[17]
pathway

Huperzine A (HupA)

Hepatic I/RI
model

Wistar rats

Antioxidation stress;
antiapoptosis

Gypenoside (GP)

Hepatic I/RI
model

C57BL/6 mice

Antioxidation stress;
antiapoptosis

Glycyrrhizin (GL)/
Glycyrrhizic acid

Hepatic I/RI
model

SD rats

Antioxidation stress

Triptolide (diterpenoid
triepoxide)

Hepatic I/RI
model

C57BL/6
mice,
splenocytes

Anti-inﬂammatory
response

Hepatic I/RI
model

SD rats

Anti-inﬂammatory
response

TLR4/NF-κB
pathway

Xiao
et al. [18]

BALB/c mice

Anti-inﬂammatory
response; antiapoptosis

ERK/NF-κB
pathway

Yu et al.
[19]

SD rats

Anti-inﬂammatory
response

NF-κB signaling Chen
pathway
et al. [20]

C57BL/6 mice

Anti-inﬂammatory
response

NF-κB signaling Liu et al.
pathway
[21]

Puerarin/7, 4dihydroxyisoﬂavone-8βglucopyranoside
Levo-tetrahydropalmatine
(L-THP)
Astragaloside IV (AST-IV)

Hepatic I/RI
model
Liver
transplantation
model
Hepatic I/RI
model

Chinese
medicine mixture

Xuebijing (XBJ)

Ginkgo biloba leaf

Ginkgo biloba Dropping
Pill (GBDP)

Hepatic I/RI
model

C57BL/6
mice,
hepatocytes

Antiapoptosis

—

Wang
et al. [22]

Chinese
medicine mixture

Berberine

Liver
transplantation
model

Wistar rats

Inhibiting endoplasmic
reticulum stress

—

Zhang
et al. [23]

inﬂammatory cytokines, and chemokines. These events
trigger the apoptotic pathway and ultimately lead to organ
failure [24]. According to current researches, the protective eﬀect of TCMs on liver I/R is mainly involved in
several mechanisms: antioxidation stress, anti-inﬂammatory
response, antiapoptosis, and inhibiting endoplasmic reticulum stress. Also, there are two main models used
in animal experiments: the hepatic I/RI model and liver
transplantation model.

2.1. Antioxidative Stress. It is well known that oxidative
stress and reactive oxygen intermediates play important
roles in liver ischemia-reperfusion injury. Free radicals
formed by oxidative stress damage the cell membrane of
hepatocytes through lipid peroxidation or/and other means.
Furthermore, these free radicals can cause extensive damage
to DNA and proteins, which can eventually lead to acute and
chronic liver damage [25–27]. Lots of research studies are
focused on antioxidant compounds extracted from herbal
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medicines to address the mechanism of its clinical protective
eﬀect to liver I/R injury.
In I/RI model rats, Atractylodes macrocephala polysaccharide (AMP), the principal bioactive component of
Atractylodes macrocephala, signiﬁcantly inhibited lipid
peroxidation and altered the activities of the antioxidant
enzyme, superoxide dismutase, and malondialdehyde level,
which is associated with its antioxidant properties and inhibition of NF-κB activation [7]. Saﬀron ethanol extract
(SEE) contains abundant ﬂavonoid compounds with antioxidant eﬀect [28]. A study found that SEE could reduce
liver IR damage by scavenging free radicals, maintaining
physiological ROS level, and attenuating oxidation-mediated chaperone carbonylation [8]. Mitochondria are the
main source of ROS in cells. Mitochondrial damage leads to
an increase in ROS production, which results in oxidative stress [29]. Mitofusin 2 (Mfn2), located in the outer
mitochondrial membrane, has the function of controlling
mitochondrial metabolism [30]. Lou et al. found that breviscapine, a ﬂavonoid compound extracted from the natural
plant Erigeron breviscapus [31], could attenuate liver I/R
injury by reducing lipid peroxidation and downregulating
the expression of Mfn2 via inhibiting the Ras-PI3K-Akt
pathway [9]. Caﬀeic acid (CA), a single phenolic acid derived
from Salvia miltiorrhiza [32], is associated with chondriosome. It was found to have a protective eﬀect on I/RI by
reducing liver microcirculation disturbance and oxidative
damage through regulating Sirt3 and the mitochondrial
respiratory chain [10]. Further research shows that PDIA3
(protein disulﬁde isomerase A3) activates NADPH oxidase
and causes the burst of ROS. CA may protect the transplanted liver by inhibiting PDIA3-NADPH oxidase [11].
TCMs exert hepatic ischemia-reperfusion injury protection
through antioxidative stress which is also observed in
huperzine A (HupA), gypenoside (GP), and glycyrrhizin
(GL) [14–16].
2.2. Anti-Inﬂammatory Response. The liver undergoes a
strong inﬂammatory process during ischemia and reperfusion injury. This liver inﬂammation is initially triggered by
ischemia. However, the inﬂammation mainly occurs during
the reperfusion phase and is characterized by the recruitment of large numbers of neutrophils in the liver. The
production of cytokines, chemokines, and danger signals
activates resident liver cells, white blood cells, and Kupﬀer
cells [33]. The following research studies have authenticated
that TCMs attenuate liver ischemia and reperfusion injury
through an anti-inﬂammatory response pathway.
Ischemia reperfusion is considered to be a complex
cascade of inﬂammatory mediators involved in the pathogenesis of liver injury. Diﬀerent from caﬀeic acid, although
magnesium lithospermate B (MLB) and Tanshinone IIA
(Tan IIA) are also the main components of Salvia miltiorrhiza, they mainly exert anti-inﬂammatory eﬀects. MLB can
prevent the activation of inﬂammatory signaling pathways,
reduce the expression of inﬂammatory mediators, and decrease the inﬁltration of macrophages and neutrophils,
thereby reducing the damage of liver cells induced by IR
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[12]. It was reported that IL-17 contributes to the accumulation of neutrophils in the inﬂammatory liver.
Triptolide, a puriﬁed ingredient of shrub-like vine Tripterygium
wilfondii Hook F, can reduce the expression of IL-17 by
inhibiting transcription 3 (STAT3) phosphorylation, thereby
inhibiting the recruitment of neutrophils in the process of
liver I/R [17]. In addition, there is evidence that Tan IIA
pretreatment can reduce inﬂammation inﬁltration and liver
damage. The underlying mechanism may be that Tan IIA
inhibits the Toll-like receptors 4 (TLR4) signaling pathway, thereby enhancing the expression of HO-1 and reducing the expression of liver proinﬂammatory cytokines
[13]. In Xiao’s experiment, puerarin nanoparticle synthesis
signiﬁcantly decreased the TLR4 and NF-κB expressions,
which showed that puerarin can display its protective role
by restraining the activation of proinﬂammatory factors
through the TLR4/NF-κB fashion [18].
Proinﬂammatory cytokines such as TNF-α and IL-6
play a key role in liver I/R injury. It has been found that
levo-tetrahydropalmatine (L-THP), an active component
of Corydalis yanhusuo, can inhibit the release of TNF-α and
IL-6 induced by liver I/R, and this protective eﬀect is partly
dependent on the inhibition of the TNF-α-mediated ERK/
NF-κB pathway [19]. Similarly, astragaloside IV (AS-IV), a
small molecular saponin, protects liver against ischemiareperfusion injury by inhibiting the activation of NF-κB in
the reperfusion phase and reducing TNF-α [20]. Liu et al.
found that Xuebijing (XBJ) with protective function of
liver I/RI is largely due to its direct eﬀect on the activation of
hepatocyte inﬂammasomes and caspase-1-dependent IL-1β
production, in addition to aﬀecting the production of inﬂammatory factors/chemokines by Kupﬀer cells through
NF-κb-dependent mechanisms [21].
2.3. Antiapoptosis. Oxidative stress and/or mitochondrial
dysfunction induced by hepatic ischemia reperfusion can
eventually activate apoptotic cascade. Caspase-3 and -8 are
key members of the cysteine-aspartate-speciﬁc protease
family and have been shown to be essential for apoptosis
[34]. Hepatocyte apoptosis is one of the most important cell
death types in the process of liver I/R injury [35]. The activation of caspase-3 and caspase-8 was found in various
apoptotic cells [36], and the upregulation of caspase-3 and
caspase-8 was also found in I/R-induced liver injury, indicating that caspase-mediated apoptosis is essensial in organ
I/R injury [37]. In addition to the caspase pathway, Bcl-2
family proteins also play a key role in the regulation of
neuronal apoptosis. The following studies have demonstrated that TCMs have an eﬀective performance in hepatic
ischemic reperfusion injury through the antiapoptosis
pathway.
Moreover, HupA, an alkaloid extracted from Huperzia
serrata, can reduce liver I/R damage by reducing the expression of apoptosis-related proteins caspase-3, Bcl-2, and
Bax [14]. The antiapoptotic eﬀect of GP, the main ingredient
of Gynostemma pentaphyllum, is related to the inhibition of
I/R-induced increase in the activities of proapoptotic proteins Bax, cytochrome c, and caspase-3/8, as well as the
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decrease in the level of antiapoptotic protein Bcl-2 [15]. In
Wang’s study, it was shown that the Ginkgo biloba Dropping
Pill (GBDP) can inhibit the expression of apoptosis-related
protein markers in vitro. Consistent with the results of in
vitro experiments, animal experiments conﬁrmed that
GBDP can downregulate the expression of proapoptotic
proteins and reduce hepatocyte apoptosis caused by liver
I/R injury [22].
2.4. Inhibition of Endoplasmic Reticulum Stress. Endoplasmic
reticulum (ER) stress refers to the continuous accumulation
of misfolded or unfolded proteins in the endoplasmic reticulum lumen, which activate the unfolded protein response
(UPR) under pathological conditions. In a steatotic liver,
endoplasmic reticulum stress is considered to be the main
cause of posttransplant injury [38].
Zhang et al. found that berberine (BBR), a compound
derived from the traditional Chinese medicine plants, inhibits endoplasmic reticulum stress-mediated phagocytosis
in steatotic liver transplantation. It is the ﬁrst report that
addresses the protective function of BBR on steatosis liver
transplantation, but the speciﬁc mechanism involved still
remains unclear [23]. Besides, saﬀron ethanol extract can
also relieve the endoplasmic reticulum stress and protein
ubiquitination induced by liver I/R [8].

3. Conclusions and Prospects
Through this review, we get some similarities from articles
published in recent years. Firstly, traditional Chinese
medicines with protective eﬀect of liver I/R injury are mostly
the main active substances of Chinese medicines. Secondly,
TCMs protect liver function via multiple mechanisms, including antioxidation, anti-inﬂammatory, inhibition of cell
apoptosis, and inhibition of endoplasmic reticulum stress, of
which antioxidant and anti-inﬂammatory eﬀects are most
commonly reported. Also, the NF-κB signaling pathway is
the most frequently involved signaling pathway. Thirdly,
diﬀerent components of traditional Chinese medicines may
exert protective eﬀects through diﬀerent mechanisms.
Lastly, the speciﬁc signaling pathways involved in these
mechanisms remain unkown.
In conclusion, traditional Chinese medicine has
protective eﬀect on liver I/R injury. However, future
research should pay more attention to in-depth mechanism
exploration rather than just descriptive observations.
Moreover, research should also clarify which components of Chinese medicine mainly play a protective role
in liver ischemia reperfusion. Furthermore, it is necessary to conduct experiments both in vivo and in vitro to
increase the convincing power of the experimental results. Finally, large sample, randomized, double-blind,
placebo-controlled, and multicenter clinical trials are
still in need.
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